Ibrutinib (PCI-32765), the first BTK (Bruton's tyrosine kinase) inhibitor in clinical trials (Q34321304)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Ibrutinib (PCI-32765), the first BTK (Bruton's tyrosine kinase) inhibitor in clinical trials |
scientific article |
Statements
1 reference
Ibrutinib (PCI-32765), the first BTK (Bruton's tyrosine kinase) inhibitor in clinical trials (English)
1 reference
Jennifer R Brown
1 reference
1 March 2013
1 reference
1 reference
8
1 reference
1
1 reference
1-6
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference